drugset / Trial / NCT06962657
Mitigating Toxic Impact: The Role of Coenzyme Q10 in Post-Exposure Protection
RandomizedCrossoverQuadruple-blindTreatment
Summary
This research study is being conducted to see if coenzyme Q10 (a nutritional supplement) might help to prevent and/or alleviate symptoms and health consequences and help to improve quality of life and physical function in residents affected by the February 2023 East Palestine, Ohio train derailment. This is a pilot study that is not powered to achieve benefit but seek to examine effect size and variance to aid in power calculations for a potential future better powered study.
Timeline
- Start
- 2026-05-15
- Primary completion
- 2028-10-01
- Completion
- 2028-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Coenzyme Q10 | Other / unclassified | 100 mg | Oral |
Indications
No indication recorded.